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PERSPECTIVE
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Here we have reviewed the conventional deﬁnitions and fundamental characteristics of the two basic types of stem cells,embryonic
stem cells (ESCs)and somatic stem cells (SSCs) . By taking into account the often-overlooked asymmetric cell kinetics of SSCs, we
consider the evidence that should SSCs retain these growth kinetics in vitro, a natural kinetic barrier to SSC propagation exists.
Recent discoveries showing that the tumor suppressor gene p53 can act as a regulator of asymmetric cell kinetics provide a target
pathway for in vitro SSC propagation strategies.
Early experiments by cell histologists such as Leblond in-
ferred the existence of pluripotent progenitor cells, or stem
cells [1, 2]. As stem cell research progressed, it became ap-
parent that there existed two basic types of stem cells (Fig-
ure 1). The ﬁrst, ESCs, are derived from blastocysts and are
sufﬁciently undifferentiated to allow them to give rise to any
adult tissue [3]. This pluripotency can be seen in the abil-
ity of ESCs to be incorporated into developing mouse em-
bryos during transgenic mouse production [4]. The other
major type, SSCs, are stem cell populations found in speciﬁc
adult tissues that are thought to divide indeﬁnitely with re-
stricted in vivo differentiation capacity [5]. SSC properties
have classically been demonstrated by reconstitution of the
ablated hematopoietic system of irradiated mice with a sub-
population of bone marrow or fetal liver cells [6].
Thevalueof isolatingandcharacterizingpureSSCpopu-
lationsisenormous.Already,currentstemcelltechnologyhas
yielded important disease therapies and research tools (e.g.,
bone marrow transplants and transgenic mice). Aside from
genetherapyapplications,anunderstandingofbasicstemcell
biology could have major impact in the ﬁelds of aging, de-
velopment, and cancer. In addition, stem cell breakthroughs
may provide the ideal building blocks needed for successful
tissue engineering. While both ESCs and SSCs may be suited
for these roles, studies with SSCs lack the moral and ethical
dilemmasencounteredinresearchwithhumanESCs[7].Fur-
thermore,theidealfuturestemcellgenetherapyapplications
should make use of autologous cells in order to minimize
therisksof immunologicalrejectionanddiseasecontraction.
Thus, the need for isolation and propagation of pure popu-
lations of SSCs is essential.
Mostof thecurrentSSCisolationandpropagationstrate-
giesarebasedonafunctionaldeﬁnitionof SSCsthathasbeen
developed mostly from hematopoietic studies. These now
classic bone marrow experiments-turned-treatments have
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Figure 1: ESCs versus SSCs. Two basic type of stem cells exist, the
ESC and the SSC. ESCs are derived from blastocysts and divide with
exponential cell kinetics. SSCs, however, are derived from somatic
tissues and divide with asymmetric cell kinetics.
provided a concise functional deﬁnition of SSCs. Namely,
convention now deﬁnes SSCs simply by scoring a cell-
population’sabilitytoreplenishorregeneratetheentiretissue
of which it is a part. Despite caveats, such as performing ex-
periments in lethally irradiated animals, this deﬁnition has
thus far served researchers well. Using it, various fractiona-
tionandpuriﬁcationtechniques(e.g.,immunomagneticsep-
arationandﬂuorescence-activatedcellsorting)havebeende-
veloped to greatly enrich for HSCs [8–10]. While the value
of these particular cells for hematopoietic replacement ther-
apy is unquestioned,the need for stem cells from other tissue
systems is equally vital. Moreover, no known method cur-
rently used to enrich for HSCs has been able to purify them
to homogeneity.
Onemajorobstaclestandinginthewayof SSCisolations,
suchasHSCs,isthelackof aphysicalidentiﬁerforSSCs.Ide-26 J. R. Merok and J. L. Shirley 1:1 (2001)
ally, this physical identiﬁer (e.g., a speciﬁc gene product or a
setofgeneproductsresponsibleforstemcellqualities)should
be directly related to unique characteristics or qualities that
are shared by all SSCs. Since no known cell-surface markers
currently used to enrich for HSCs have been shown to pro-
videapurepopulationof SSCs,[8–10]itseemsworthwhileto
consider other stem cell characteristics, in addition to tissue
regeneration potential, to aid in the search for physical iden-
tiﬁers. One such characteristic is predicted to be asymmetric
cell kinetics [11,12].
In vitro cultures of immortal cells are commonly used in
mammalian cell research. These cell lines, often transformed
andtypicallyharboringmutationsinthe p53tumorsuppres-
sor gene,grow with exponential kinetics [13]. This program,
i nw h i c h1c e l lb e g e t s2 ,2b e g e t4 ,4b e g e t8 ,a n ds oo nad
inﬁnitum, is almost never found in the healthy somatic cells
of adult mammals [14]. Instead, many adult somatic tissues
undergo cell turnover in accordance with an asymmetric cell
kinetics program, whereby stem cell division gives rise to (1)
another stem cell and (2)a transit cell destined to produce
a terminally differentiated lineage [14–16]. Once explanted,
Rambhatla and others (this issue)postulate that tissue cells
continue with a rudimentary form of this pattern in vitro.
They propose that continued somatic stem cell kinetics in
vitro results in the well-documented “senescence” behavior
observed in many primary cultures [17, 18].
Now, with the suggestion that many primary cells divide
withasymmetrickinetics,thepastdifﬁcultieswithSSCprop-
agation in culture is not surprising. Even starting with a pop-
ulation of pure stem cells, transit cells are soon produced.
Eventually, the culture ﬂasks become replete and need to be
passaged.Byseedinganewﬂaskwithaportionoftheoldﬂask
(standard cell culture technique), the total stem cell number
perﬂaskdwindles.Thisdiluting-outof stemcellsnotonlyre-
sults in heterogeneous cultures, but it also sets up a selective
pressurefavoringcellswithgrowth-activatingmutationsthat
disrupt the asymmetric cell kinetics program. This kinetic
barrier to SSC propagation will have to be faced no matter
what method of stem cell isolation is used, and it may ulti-
mately be the major obstacle to maintaining wild-type stem
cell strains in vitro.
In an attempt to understand the kinetic barrier to SSC
propagation,Rambhatlaandothershaveengineeredcelllines
that conditionally express a protein which is mutated in an
astonishingly large number of immortalized cells—the tu-
mor suppressor p53. The result has been cell lines that grow
with inducible asymmetric cell kinetics. The implications,
not only for the ﬁeld of basic p53 research, but for actual
SSC propagation in vitro are quite important. To be ex-
act, p53 expression has been shown to control asymmetric
kinetics through control of inosine-5 -monophosphate de-
hydrogenase (IMPD), the rate-limiting enzyme for guanine
nucleotide synthesis [19, 20]. As such, this regulatory path-
way may be the key to controlling asymmetric kinetics in
SSCs,thus ultimately allowing both the elucidation of physi-
cal identiﬁers of stem cells and the propagation of true wild-
type SSCs in vitro.
Inconclusion,althoughattemptstopurifySSCshavebeen
partially successful, no presently applied technology can iso-
late pure SSCs. With the present lack of a true physical iden-
tiﬁer of SSCs, functional deﬁnitions, such as tissue recon-
stitution potential, must be used in puriﬁcation strategies.
One often-overlooked functional deﬁnition of SSCs is asym-
metric cell kinetics. This functional deﬁnition leads to the
important realization that even with a pure SSC population,
in vitro propagation will be impossible without addressing
the kinetic barrier posed by their unique cell kinetics pro-
gram. Advances in understanding this kinetic barrier have
been made by Rambhatla and others that point to the tumor
suppressor p53 (working through cellular guanine ribonu-
cleotide pools)as an important regulator of asymmetric cell
kinetics.Thus,engineeredperturbationsof thispathwaymay
ultimately lead to successful SSC isolation and propagation
in vitro.
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